Acceptability of Autonomous Artificial Intelligence-Based Diabetic Ret

Acceptability of Autonomous Artificial Intelligence-Based Diabetic Ret

Introduction Diabetic retinopathy (DR) is a leading cause of blindness in working-age adults.1 Early detection of…

Continue Reading
AEYE Health and Ford Medical Partner to Bring Fully Autonomous, Reimbursable AI Diabetic Eye Exam Screening Solutions to Pharmacies

AEYE Health and Ford Medical Partner to Bring Fully Autonomous, Reimbursable AI Diabetic Eye Exam Screening Solutions to Pharmacies

NEW YORK, July 15, 2025 /PRNewswire/ — AEYE Health, a leader in AI-powered retinal diagnostics, announces…

Continue Reading
AEYE Health in partnership with Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening

AEYE Health in partnership with Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening

Powerful combination delivers immediate, dilation-free, fully autonomous AI diagnostic screening with 100% imageability for referable diabetic…

Continue Reading
Oracle launches Autonomous Shield initiative, with eye on cloud cybersecurity

Oracle launches Autonomous Shield initiative, with eye on cloud cybersecurity

At its first-ever Health Summit in Nashville on Tuesday, Oracle announced a new cybersecurity-focused service for…

Continue Reading